Dedicated to Excellence in Pharmaceutical Access
TGA, S19A, Special Access Scheme
At Pro Pharmaceuticals Group, we specialize in addressing medicine shortages across Australia with speed and precision. Leveraging our expertise and global network, we navigate complex regulatory frameworks, including the TGA S19A Special Access Scheme, to ensure patients receive essential treatments when they need them most.
Medicine Shortages and TGA S19A Access
Expertise
Partnering with Healthcare Providers
​At Pro Pharmaceuticals Group, we specialise in sourcing both licensed and unlicensed pharmaceuticals to address urgent gaps in medicine availability. Our unwavering commitment to patient care drives us to provide comprehensive solutions, including access to TGA S19A-approved medicines that meet pressing healthcare needs. Through our global network of trusted suppliers, we ensure reliable sourcing while maintaining strict regulatory compliance.
Our expertise in navigating the Special Access Scheme allows us to deliver these critical treatments seamlessly, enabling uninterrupted patient care. With a focus on quality, compliance, and efficiency, we bridge gaps in supply to uphold the highest standards of safety.
We understand the significant challenges hospitals, pharmacies, and healthcare organizations face during medicine shortages. Pro Pharmaceuticals Group offers tailored support by providing customized solutions that address the unique needs of patients and healthcare providers.
Our end-to-end services include sourcing, procurement, and compliant delivery and distribution. With robust supply chain management, we ensure reliable access to critical medicines, empowering healthcare providers to deliver uninterrupted care.
Our dedicated team remains focused on ensuring that no patient is left without the treatment they require.
